Intellectual Property and Emerging Technologies: The New Biology

Front Cover
Matthew Rimmer, Alison McLennan
Edward Elgar Publishing, Jan 1, 2012 - Technology & Engineering - 512 pages
0 Reviews
This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Inventing life intellectual property and the New Biology
1
PART I A history of biodiscovery
37
circulating knowledge
39
PART II Medicine biotechnology and genomics
61
back to the future?
63
3 The current state of patent eligibility of medical and biotechnological inventions in the United States
84
4 Patent law the emerging biotechnologies and the role of language in subjectmatter expansionism
117
PART III Biobanks bioinformatics and BioBricks
131
PART IV Genetics stem cells and nanotechnology
203
patenting small RNAs
205
looking for serenity
228
patent law and nanotechnology
255
PART V Biodiversity food security and climate change
291
biodiscovery intellectual property and Indigenous knowledge
293
intellectual property agriculture and climate change
320
seed banks food security and climate change
361

5 Standards for biobank access and intellectual property
133
6 The 1000 Genomes Project
158
constructing a commons for synthetic biology research
176
Bibliography
392
Index
457
Copyright

Other editions - View all

Common terms and phrases

About the author (2012)

Matthew Rimmer is a senior lecturer and associate director of research at the ANU College of Law, and an associate director of the Australian Centre for Intellectual Property in Agriculture.

Bibliographic information